Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease
Open Access
- 5 September 2002
- Vol. 95 (6) , 1311-1316
- https://doi.org/10.1002/cncr.10816
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Response of primary leptomeningeal melanoma to intrathecal recombinant interleukin‐2: A case reportCancer, 1996
- Distinct cognitive profiles of cortical and subcortical dementia in advanced illnessNeurology, 1995
- Reversible neurotoxicity of interleukin-2 and tumor necrosis factor: correlation of SPECT with neuropsychological testingThe Journal of Neuropsychiatry and Clinical Neurosciences, 1994
- The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsyZeitschrift für Neurologie, 1994
- Delayed neurotoxicity of intraventricular interleukin-2: A case reportJournal of Neuro-Oncology, 1993
- Prognostic factors for high-grade malignant glioma: Development of a prognostic indexJournal of Neuro-Oncology, 1990
- Differentiation of Alzheimer's Disease and Huntington's Disease With the Dementia Rating ScaleArchives of Neurology, 1989
- Leptomeningeal metastases: Reduction in regional cerebral blood flow and cognitive impairmentAnnals of Neurology, 1985
- “Mini-mental state”Journal of Psychiatric Research, 1975